Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
---|---|---|---|---|---|
31.03. | NT PHARMA (01011): ANNOUNCEMENT OF AUDITED ANNUAL RESULTS FOR THE YEAR ENDED 31 DECEMBER 2024 | - | HKEx | ||
20.03. | NT PHARMA (01011): CLARIFICATION ANNOUNCEMENT IN RELATION TO DATE OF BOARD MEETING | - | HKEx | ||
19.03. | NT PHARMA (01011): DATE OF BOARD MEETING | 1 | HKEx | ||
21.02. | NT PHARMA (01011): NEXT DAY DISCLOSURE RETURN | 1 | HKEx | ||
21.02. | NT PHARMA (01011): COMPLETION OF CONNECTED TRANSACTION IN RELATION TO LOAN CAPITALIZATION INVOLVING SUBSCRIPTION OF SHARES UNDER SPECIFIC MANDATE | - | HKEx | ||
CHINA NT PHARMA Aktie jetzt für 0€ handeln | |||||
17.02. | NT PHARMA (01011): (1) POLL RESULTS OF THE EXTRAORDINARY GENERAL MEETING HELD ON 17 FEBRUARY 2025; AND (2) GRANT OF WHITEWASH WAIVER | 2 | HKEx | ||
04.02. | NT PHARMA (01011): SUPPLEMENTAL ANNOUNCEMENT | - | HKEx | ||
28.01. | NT PHARMA (01011): DESPATCH OF THE CIRCULAR IN RELATION TO (1) CONNECTED TRANSACTION IN RELATION TO LOAN CAPITALIZATION INVOLVING SUBSCRIPTION OF SHARES ... | 1 | HKEx | ||
27.01. | NT PHARMA (01011): NOTIFICATION LETTER AND REPLY FORM TO REGISTERED SHAREHOLDER | 2 | HKEx | ||
27.01. | NT PHARMA (01011): NOTIFICATION LETTER AND REQUEST FORM TO NON-REGISTERED HOLDER | 1 | HKEx | ||
27.01. | NT PHARMA (01011): FORM OF PROXY FOR THE EXTRAORDINARY GENERAL MEETING TO BE HELD ON MONDAY, 17 FEBRUARY 2025 | - | HKEx | ||
27.01. | NT PHARMA (01011): (1) CONNECTED TRANSACTION IN RELATION TO LOAN CAPITALIZATION INVOLVING SUBSCRIPTION OF SHARES UNDER SPECIFIC MANDATE; (2) APPLICATION ... | 2 | HKEx | ||
27.01. | NT PHARMA (01011): NOTICE OF EXTRAORDINARY GENERAL MEETING | 1 | HKEx | ||
20.01. | NT PHARMA (01011): MONTHLY UPDATE ANNOUNCEMENT ON (1) CONNECTED TRANSACTION IN RELATION TO LOAN CAPITALIZATION INVOLVING SUBSCRIPTION OF SHARES UNDER ... | 1 | HKEx | ||
08.01. | NT PHARMA (01011): PROFIT WARNING AND INSIDE INFORMATION ANNOUNCEMENT UPDATE ON FINANCIAL INFORMATION | 1 | HKEx | ||
19.12.24 | NT PHARMA (01011): DELAY IN DESPATCH OF THE CIRCULAR RELATING TO (1) CONNECTED TRANSACTION IN RELATION TO LOAN CAPITALIZATION INVOLVING SUBSCRIPTION OF ... | 2 | HKEx | ||
28.11.24 | NT PHARMA (01011): (1) CONNECTED TRANSACTION IN RELATION TO LOAN CAPITALIZATION INVOLVING SUBSCRIPTION OF SHARES UNDER SPECIFIC MANDATE; AND (2) APPLICATION ... | - | HKEx | ||
08.11.24 | NT PHARMA (01011): MONTHLY UPDATE ANNOUNCEMENT PURSUANT TO RULE 3.7 OF THE TAKEOVERS CODE | - | HKEx |
Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
---|---|---|---|---|---|
AURORA CANNABIS | 3,860 | -1,28 % | Aurora Cannabis Inc (3): Aurora Cannabis offers inhalers to U.K. patients | ||
CANOPY GROWTH | 1,052 | +0,77 % | Canopy Growth: Reverse-Split droht | Die Aktie von Canopy Growth kennt weiterhin nur die Richtung nach unten. Mittlerweile notiert sie sogar unter der 1-Dollar-Marke und ist damit offiziell ein Pennystock. Das ist nicht nur aus Imagesicht... ► Artikel lesen | |
TILRAY BRANDS | 0,400 | +0,78 % | Tilray Brands, Inc.: Tilray Brands Announces Proposed Reverse Stock Split and Corresponding Special Meeting of Stockholders | NEW YORK and LEAMINGTON, Ontario, April 17, 2025 (GLOBE NEWSWIRE) -- Tilray Brands, Inc. ("Tilray" or "Company") (Nasdaq: TLRY; TSX: TLRY), a global lifestyle and consumer packaged goods company at... ► Artikel lesen | |
DIGICANN VENTURES | 0,004 | 0,00 % | Digicann Ventures Inc: Digicann Ventures extends debentures | ||
WPD PHARMACEUTICALS | 0,050 | 0,00 % | CSE Bulletin: Consolidation - WPD Pharmaceuticals Inc. (WBIO) | le 23 décembre/December 2024
WPD Pharmaceuticals Inc. has announced a consolidation of its issued and outstanding common shares on the basis of one (1) post-consolidated common share for every twenty-five... ► Artikel lesen | |
SINOPHARM | 1,990 | +0,35 % | Leichte Zugewinne bei der Sinopharm Group-Aktie (2,569 €) | An der Börse notiert das Wertpapier der Sinopharm Group aktuell fester. Die Aktie kostete zuletzt 2,57 Euro. Jahreschart der Sinopharm Group Ltd.-Aktie, Stand 06.01.2025 Freuen können sich gegenwärtig... ► Artikel lesen | |
INDIVA | 0,016 | -100,00 % | SNDL Inc.: SNDL Emerges as Canada's Leading Producer of Edibles with Indiva Acquisition | CALGARY, AB, Nov. 4, 2024 /CNW/ - SNDL Inc. (Nasdaq: SNDL) ("SNDL" or the "Company") announced today that, in the context of Indiva Limited's ("Indiva" and together... ► Artikel lesen | |
CSPC PHARMA | 0,602 | -2,21 % | Aktienmarkt: CSPC Pharmaceutical Group-Aktie kann sich nicht behaupten (0,6116 €) | Im Wertpapierhandel notiert das Wertpapier der CSPC Pharmaceutical Group derzeit leichter. Das Papier kostete zuletzt 0,61 Euro. Jahreschart der CSPC Pharmaceutical Group Ltd-Aktie, Stand 17.04.2025... ► Artikel lesen | |
ORAMED PHARMACEUTICALS | 1,904 | -1,42 % | Oramed Aktie: Besorgniserregende Signale? | Die Oramed Pharmaceuticals Aktie verzeichnete am 22. Februar 2025 einen signifikanten Rückgang. Der Aktienkurs fiel um 3,15 Prozent auf 2,15 USD, was einem Minus von 0,07 USD gegenüber dem vorherigen... ► Artikel lesen | |
ADASTRA | 0,182 | 0,00 % | Adastra Holdings Ltd.: Adastra Holdings Announces New Director | Langley, British Columbia--(Newsfile Corp. - March 3, 2025) - Adastra Holdings Ltd. (CSE: XTRX) (FSE: D2EP) ("Adastra" or the "Company"), a leading cannabis processor and producer of two top Canadian... ► Artikel lesen | |
CATALYST PHARMACEUTICALS | 19,805 | -0,10 % | Catalyst Pharmaceuticals, Inc.: Catalyst Pharmaceuticals Announces Health Canada's Acceptance of AGAMREE New Drug Submission with Priority Review for Sub-Licensee Kye Pharmaceuticals | CORAL GABLES, Fla., April 08, 2025 (GLOBE NEWSWIRE) -- Catalyst Pharmaceuticals, Inc. ("Catalyst" or "Company") (Nasdaq: CPRX), a commercial-stage biopharmaceutical company focused on in-licensing... ► Artikel lesen |